Thanaboon Chaemsupaphan

9PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityMedical biochemistry - lipidsPredictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 22, 2026
Vedolizumab in inflammatory bowel disease: pharmacokinetics and the role of immunomodulator co-therapy.

Aviv Pudipeddi, Thanaboon Chaemsupaphan, Arteen Arzivian

|Nov 03, 2025
Microbiota-targeted strategies in IBD: therapeutic promise of 2'-fucosyllactose and beyond.

Nicholas Fanous, Nicholas J Talley, Thanaboon Chaemsupaphan

|Aug 22, 2025
Asia Pacific association of gastroenterology consensus statements on histopathological evaluation of inflammatory bowel diseases.

Rupert W Leong, Thanaboon Chaemsupaphan, Huiyu Lin

|Jul 30, 2025
Self-Injection Satisfaction and Safety of CT-P17 (Yuflyma), a High-Concentration Adalimumab Biosimilar, in Patients With Crohn's Disease: A Cross-Sectional Study.

Fei Yang Pan, Thanaboon Chaemsupaphan, Sacha Cartwright

|Feb 26, 2025
The Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease in Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis.

Suvijak Untaaveesup, Piyawat Kantagowit, Patompong Ungprasert

|Jan 06, 2025
Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on Vedolizumab.

Thanaboon Chaemsupaphan, Aviv Pudipeddi, Huiyu Lin

Pageof 2

Frequent Collaborators

6 joint publications

Rupert W Leong

3 joint publications

Viraj Kariyawasam

1 joint publications

Anthony Sakiris

1 joint publications

Arteen Arzivian